BioSpace News Archive

Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced the appointment of Kenneth J. Bloom, MD, FCAP as the company’s new head of pathology.

Octet Scientific, Inc. has been awarded $1 Million from the U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) program to conduct research and development (R&D) work on making safer and more sustainable grid-scale battery storage.

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), today announced that it will release its financial results and business update for the second quarter of 2022 on Thursday, August 11, 2022, at the close of the U.S. financial markets.

Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announced the execution of a Commercial License and Enzyme Supply Agreement, enabling Molecular Assemblies to utilize an evolved terminal deoxynucleotidyl transferase enzyme in Molecular Assemblies’ Fully Enzymatic Synthesis™ technology.

Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced that Chinook management is scheduled to participate in the following upcoming investor conferences.

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its second quarter 2022 financial and operating results after the close of U.S. financial markets on Tuesday, August 9, 2022.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended June 30, 2022 and provided an update on key milestones.

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today second quarter financial results for the three-months ended June 30, 2022.

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the Company’s XTRAC Excimer Laser will be highlighted in an upcoming Key Opinion Leader Call hosted by Ladenburg Thalmann.

Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its second quarter 2022 financial results on Tuesday, August 9, 2022, after the market closes.